img

Global Pharma Excipients Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pharma Excipients Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Pharma Excipients market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Pharma Excipients is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The China market for Pharma Excipients is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The Europe market for Pharma Excipients is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034..
The global key manufacturers of Pharma Excipients include Archer Daniels Midland (ADM), BASF, DOW Chemical Company, Evonik, J.M. Huber Corporation, ABITEC Corporation, Cargill, Eastman Chemical Company and AkzoNobel, etc. In 2024, the global top five players hold a share approximately % in sales volume, and in term of revenue of Pharma Excipients, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Pharma Excipients by regions (Countries), company, by type and by type. from 2018 to 2023 and forecast to 2034.
The global Pharma Excipients market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Pharma Excipients market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Archer Daniels Midland (ADM)
BASF
DOW Chemical Company
Evonik
J.M. Huber Corporation
ABITEC Corporation
Cargill
Eastman Chemical Company
AkzoNobel
By Type
Polymers
Alcohols
Minerals
Sugar
Others
By Application
Oral Solid Dosage Forms (OSDF)
Others
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Pharma Excipients in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Pharma Excipients manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharma Excipients sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Pharma Excipients Definition
1.2 Market by Type
1.2.1 Global Pharma Excipients Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Polymers
1.2.3 Alcohols
1.2.4 Minerals
1.2.5 Sugar
1.2.6 Others
1.3 Market Segment by Application
1.3.1 Global Pharma Excipients Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Oral Solid Dosage Forms (OSDF)
1.3.3 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Pharma Excipients Sales
2.1 Global Pharma Excipients Revenue Estimates and Forecasts 2018-2034
2.2 Global Pharma Excipients Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Pharma Excipients Revenue by Region
2.3.1 Global Pharma Excipients Revenue by Region (2018-2023)
2.3.2 Global Pharma Excipients Revenue by Region (2024-2034)
2.4 Global Pharma Excipients Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Pharma Excipients Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Pharma Excipients Sales Quantity by Region
2.6.1 Global Pharma Excipients Sales Quantity by Region (2018-2023)
2.6.2 Global Pharma Excipients Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Pharma Excipients Sales Quantity by Manufacturers
3.1.1 Global Pharma Excipients Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Pharma Excipients Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Pharma Excipients Sales in 2024
3.2 Global Pharma Excipients Revenue by Manufacturers
3.2.1 Global Pharma Excipients Revenue by Manufacturers (2018-2023)
3.2.2 Global Pharma Excipients Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Pharma Excipients Revenue in 2024
3.3 Global Pharma Excipients Sales Price by Manufacturers
3.4 Global Key Players of Pharma Excipients, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pharma Excipients Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pharma Excipients, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pharma Excipients, Product Offered and Application
3.8 Global Key Manufacturers of Pharma Excipients, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Pharma Excipients Sales Quantity by Type
4.1.1 Global Pharma Excipients Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Pharma Excipients Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Pharma Excipients Sales Quantity Market Share by Type (2018-2034)
4.2 Global Pharma Excipients Revenue by Type
4.2.1 Global Pharma Excipients Historical Revenue by Type (2018-2023)
4.2.2 Global Pharma Excipients Forecasted Revenue by Type (2024-2034)
4.2.3 Global Pharma Excipients Revenue Market Share by Type (2018-2034)
4.3 Global Pharma Excipients Price by Type
4.3.1 Global Pharma Excipients Price by Type (2018-2023)
4.3.2 Global Pharma Excipients Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Pharma Excipients Sales Quantity by Application
5.1.1 Global Pharma Excipients Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Pharma Excipients Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Pharma Excipients Sales Quantity Market Share by Application (2018-2034)
5.2 Global Pharma Excipients Revenue by Application
5.2.1 Global Pharma Excipients Historical Revenue by Application (2018-2023)
5.2.2 Global Pharma Excipients Forecasted Revenue by Application (2024-2034)
5.2.3 Global Pharma Excipients Revenue Market Share by Application (2018-2034)
5.3 Global Pharma Excipients Price by Application
5.3.1 Global Pharma Excipients Price by Application (2018-2023)
5.3.2 Global Pharma Excipients Price Forecast by Application (2024-2034)
6 North America
6.1 North America Pharma Excipients Sales by Company
6.1.1 North America Pharma Excipients Revenue by Company (2018-2023)
6.1.2 North America Pharma Excipients Sales Quantity by Company (2018-2023)
6.2 North America Pharma Excipients Market Size by Type
6.2.1 North America Pharma Excipients Sales Quantity by Type (2018-2034)
6.2.2 North America Pharma Excipients Revenue by Type (2018-2034)
6.3 North America Pharma Excipients Market Size by Application
6.3.1 North America Pharma Excipients Sales Quantity by Application (2018-2034)
6.3.2 North America Pharma Excipients Revenue by Application (2018-2034)
6.4 North America Pharma Excipients Market Size by Country
6.4.1 North America Pharma Excipients Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Pharma Excipients Revenue by Country (2018-2034)
6.4.3 North America Pharma Excipients Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Pharma Excipients Sales by Company
7.1.1 Europe Pharma Excipients Sales Quantity by Company (2018-2023)
7.1.2 Europe Pharma Excipients Revenue by Company (2018-2023)
7.2 Europe Pharma Excipients Market Size by Type
7.2.1 Europe Pharma Excipients Sales Quantity by Type (2018-2034)
7.2.2 Europe Pharma Excipients Revenue by Type (2018-2034)
7.3 Europe Pharma Excipients Market Size by Application
7.3.1 Europe Pharma Excipients Sales Quantity by Application (2018-2034)
7.3.2 Europe Pharma Excipients Revenue by Application (2018-2034)
7.4 Europe Pharma Excipients Market Size by Country
7.4.1 Europe Pharma Excipients Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Pharma Excipients Revenue by Country (2018-2034)
7.4.3 Europe Pharma Excipients Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Pharma Excipients Sales by Company
8.1.1 China Pharma Excipients Sales Quantity by Company (2018-2023)
8.1.2 China Pharma Excipients Revenue by Company (2018-2023)
8.2 China Pharma Excipients Market Size by Type
8.2.1 China Pharma Excipients Sales Quantity by Type (2018-2034)
8.2.2 China Pharma Excipients Revenue by Type (2018-2034)
8.3 China Pharma Excipients Market Size by Application
8.3.1 China Pharma Excipients Sales Quantity by Application (2018-2034)
8.3.2 China Pharma Excipients Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Pharma Excipients Sales by Company
9.1.1 APAC Pharma Excipients Sales Quantity by Company (2018-2023)
9.1.2 APAC Pharma Excipients Revenue by Company (2018-2023)
9.2 APAC Pharma Excipients Market Size by Type
9.2.1 APAC Pharma Excipients Sales Quantity by Type (2018-2034)
9.2.2 APAC Pharma Excipients Revenue by Type (2018-2034)
9.3 APAC Pharma Excipients Market Size by Application
9.3.1 APAC Pharma Excipients Sales Quantity by Application (2018-2034)
9.3.2 APAC Pharma Excipients Revenue by Application (2018-2034)
9.4 APAC Pharma Excipients Market Size by Region
9.4.1 APAC Pharma Excipients Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Pharma Excipients Revenue by Region (2018-2034)
9.4.3 APAC Pharma Excipients Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Pharma Excipients Sales by Company
10.1.1 Middle East, Africa and Latin America Pharma Excipients Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Pharma Excipients Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Pharma Excipients Market Size by Type
10.2.1 Middle East, Africa and Latin America Pharma Excipients Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Pharma Excipients Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Pharma Excipients Market Size by Application
10.3.1 Middle East, Africa and Latin America Pharma Excipients Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Pharma Excipients Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Pharma Excipients Market Size by Country
10.4.1 Middle East, Africa and Latin America Pharma Excipients Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Pharma Excipients Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Pharma Excipients Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Archer Daniels Midland (ADM)
11.1.1 Archer Daniels Midland (ADM) Company Information
11.1.2 Archer Daniels Midland (ADM) Overview
11.1.3 Archer Daniels Midland (ADM) Pharma Excipients Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Archer Daniels Midland (ADM) Pharma Excipients Products and Services
11.1.5 Archer Daniels Midland (ADM) Pharma Excipients SWOT Analysis
11.1.6 Archer Daniels Midland (ADM) Recent Developments
11.2 BASF
11.2.1 BASF Company Information
11.2.2 BASF Overview
11.2.3 BASF Pharma Excipients Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 BASF Pharma Excipients Products and Services
11.2.5 BASF Pharma Excipients SWOT Analysis
11.2.6 BASF Recent Developments
11.3 DOW Chemical Company
11.3.1 DOW Chemical Company Company Information
11.3.2 DOW Chemical Company Overview
11.3.3 DOW Chemical Company Pharma Excipients Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 DOW Chemical Company Pharma Excipients Products and Services
11.3.5 DOW Chemical Company Pharma Excipients SWOT Analysis
11.3.6 DOW Chemical Company Recent Developments
11.4 Evonik
11.4.1 Evonik Company Information
11.4.2 Evonik Overview
11.4.3 Evonik Pharma Excipients Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Evonik Pharma Excipients Products and Services
11.4.5 Evonik Pharma Excipients SWOT Analysis
11.4.6 Evonik Recent Developments
11.5 J.M. Huber Corporation
11.5.1 J.M. Huber Corporation Company Information
11.5.2 J.M. Huber Corporation Overview
11.5.3 J.M. Huber Corporation Pharma Excipients Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 J.M. Huber Corporation Pharma Excipients Products and Services
11.5.5 J.M. Huber Corporation Pharma Excipients SWOT Analysis
11.5.6 J.M. Huber Corporation Recent Developments
11.6 ABITEC Corporation
11.6.1 ABITEC Corporation Company Information
11.6.2 ABITEC Corporation Overview
11.6.3 ABITEC Corporation Pharma Excipients Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 ABITEC Corporation Pharma Excipients Products and Services
11.6.5 ABITEC Corporation Pharma Excipients SWOT Analysis
11.6.6 ABITEC Corporation Recent Developments
11.7 Cargill
11.7.1 Cargill Company Information
11.7.2 Cargill Overview
11.7.3 Cargill Pharma Excipients Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Cargill Pharma Excipients Products and Services
11.7.5 Cargill Pharma Excipients SWOT Analysis
11.7.6 Cargill Recent Developments
11.8 Eastman Chemical Company
11.8.1 Eastman Chemical Company Company Information
11.8.2 Eastman Chemical Company Overview
11.8.3 Eastman Chemical Company Pharma Excipients Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Eastman Chemical Company Pharma Excipients Products and Services
11.8.5 Eastman Chemical Company Pharma Excipients SWOT Analysis
11.8.6 Eastman Chemical Company Recent Developments
11.9 AkzoNobel
11.9.1 AkzoNobel Company Information
11.9.2 AkzoNobel Overview
11.9.3 AkzoNobel Pharma Excipients Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 AkzoNobel Pharma Excipients Products and Services
11.9.5 AkzoNobel Pharma Excipients SWOT Analysis
11.9.6 AkzoNobel Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Pharma Excipients Value Chain Analysis
12.2 Pharma Excipients Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pharma Excipients Production Mode & Process
12.4 Pharma Excipients Sales and Marketing
12.4.1 Pharma Excipients Sales Channels
12.4.2 Pharma Excipients Distributors
12.5 Pharma Excipients Customers
13 Market Dynamics
13.1 Pharma Excipients Industry Trends
13.2 Pharma Excipients Market Drivers
13.3 Pharma Excipients Market Challenges
13.4 Pharma Excipients Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Pharma Excipients Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Polymers
Table 3. Major Manufacturers of Alcohols
Table 4. Major Manufacturers of Minerals
Table 5. Major Manufacturers of Sugar
Table 6. Major Manufacturers of Others
Table 7. Global Pharma Excipients Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Pharma Excipients Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. Global Pharma Excipients Revenue by Region (2018-2023) & (US$ Million)
Table 10. Global Pharma Excipients Revenue Market Share by Region (2018-2023)
Table 11. Global Pharma Excipients Revenue by Region (2024-2034) & (US$ Million)
Table 12. Global Pharma Excipients Revenue Market Share by Region (2024-2034)
Table 13. Global Pharma Excipients Sales Quantity by Region: 2018 VS 2024 VS 2034 (K MT)
Table 14. Global Pharma Excipients Sales by Region (2018-2023) & (K MT)
Table 15. Global Pharma Excipients Sales Market Share by Region (2018-2023)
Table 16. Global Pharma Excipients Sales by Region (2024-2034) & (K MT)
Table 17. Global Pharma Excipients Sales Market Share by Region (2024-2034)
Table 18. Global Pharma Excipients Sales Quantity by Manufacturers (2018-2023) & (K MT)
Table 19. Global Pharma Excipients Sales Quantity Share by Manufacturers (2018-2023)
Table 20. Global Pharma Excipients Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 21. Global Pharma Excipients Revenue Share by Manufacturers (2018-2023)
Table 22. Global Pharma Excipients Price by Manufacturers 2018-2023 (USD/MT)
Table 23. Global Key Players of Pharma Excipients, Industry Ranking, 2021 VS 2024
Table 24. Global Pharma Excipients Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Pharma Excipients by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharma Excipients as of 2024)
Table 26. Global Key Manufacturers of Pharma Excipients, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Pharma Excipients, Product Offered and Application
Table 28. Global Key Manufacturers of Pharma Excipients, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Pharma Excipients Sales Quantity by Type (2018-2023) & (K MT)
Table 31. Global Pharma Excipients Sales Quantity by Type (2024-2034) & (K MT)
Table 32. Global Pharma Excipients Sales Quantity Share by Type (2018-2023)
Table 33. Global Pharma Excipients Sales Quantity Share by Type (2024-2034)
Table 34. Global Pharma Excipients Revenue by Type (2018-2023) & (US$ Million)
Table 35. Global Pharma Excipients Revenue by Type (2024-2034) & (US$ Million)
Table 36. Global Pharma Excipients Revenue Share by Type (2018-2023)
Table 37. Global Pharma Excipients Revenue Share by Type (2024-2034)
Table 38. Pharma Excipients Price by Type (2018-2023) & (USD/MT)
Table 39. Global Pharma Excipients Price Forecast by Type (2024-2034) & (USD/MT)
Table 40. Global Pharma Excipients Sales Quantity by Application (2018-2023) & (K MT)
Table 41. Global Pharma Excipients Sales Quantity by Application (2024-2034) & (K MT)
Table 42. Global Pharma Excipients Sales Quantity Share by Application (2018-2023)
Table 43. Global Pharma Excipients Sales Quantity Share by Application (2024-2034)
Table 44. Global Pharma Excipients Revenue by Application (2018-2023) & (US$ Million)
Table 45. Global Pharma Excipients Revenue by Application (2024-2034) & (US$ Million)
Table 46. Global Pharma Excipients Revenue Share by Application (2018-2023)
Table 47. Global Pharma Excipients Revenue Share by Application (2024-2034)
Table 48. Pharma Excipients Price by Application (2018-2023) & (USD/MT)
Table 49. Global Pharma Excipients Price Forecast by Application (2024-2034) & (USD/MT)
Table 50. North America Pharma Excipients Revenue by Company (2018-2023) & (US$ Million)
Table 51. North America Pharma Excipients Sales Quantity by Company (2018-2023) & (K MT)
Table 52. North America Pharma Excipients Sales Quantity by Type (2018-2023) & (K MT)
Table 53. North America Pharma Excipients Sales Quantity by Type (2024-2034) & (K MT)
Table 54. North America Pharma Excipients Revenue by Type (2018-2023) & (US$ Million)
Table 55. North America Pharma Excipients Revenue by Type (2024-2034) & (US$ Million)
Table 56. North America Pharma Excipients Sales Quantity by Application (2018-2023) & (K MT)
Table 57. North America Pharma Excipients Sales Quantity by Application (2024-2034) & (K MT)
Table 58. North America Pharma Excipients Revenue by Application (2018-2023) & (US$ Million)
Table 59. North America Pharma Excipients Revenue by Application (2024-2034) & (US$ Million)
Table 60. North America Pharma Excipients Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 61. North America Pharma Excipients Revenue by Country (2018-2023) & (US$ Million)
Table 62. North America Pharma Excipients Revenue by Country (2024-2034) & (US$ Million)
Table 63. North America Pharma Excipients Sales Quantity by Country (2018-2023) & (K MT)
Table 64. North America Pharma Excipients Sales Quantity by Country (2024-2034) & (K MT)
Table 65. Europe Pharma Excipients Sales Quantity by Company (2018-2023) & (K MT)
Table 66. Europe Pharma Excipients Revenue by Company (2018-2023) & (US$ Million)
Table 67. Europe Pharma Excipients Sales Quantity by Type (2018-2023) & (K MT)
Table 68. Europe Pharma Excipients Sales Quantity by Type (2024-2034) & (K MT)
Table 69. Europe Pharma Excipients Revenue by Type (2018-2023) & (US$ Million)
Table 70. Europe Pharma Excipients Revenue by Type (2024-2034) & (US$ Million)
Table 71. Europe Pharma Excipients Sales Quantity by Application (2018-2023) & (K MT)
Table 72. Europe Pharma Excipients Sales Quantity by Application (2024-2034) & (K MT)
Table 73. Europe Pharma Excipients Revenue by Application (2018-2023) & (US$ Million)
Table 74. Europe Pharma Excipients Revenue by Application (2024-2034) & (US$ Million)
Table 75. Europe Pharma Excipients Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 76. Europe Pharma Excipients Revenue by Country (2018-2023) & (US$ Million)
Table 77. Europe Pharma Excipients Revenue by Country (2024-2034) & (US$ Million)
Table 78. Europe Pharma Excipients Sales Quantity by Country (2018-2023) & (K MT)
Table 79. Europe Pharma Excipients Sales Quantity by Country (2024-2034) & (K MT)
Table 80. China Pharma Excipients Sales Quantity by Company (2018-2023) & (K MT)
Table 81. China Pharma Excipients Revenue by Company (2018-2023) & (US$ Million)
Table 82. China Pharma Excipients Sales Quantity by Type (2018-2023) & (K MT)
Table 83. China Pharma Excipients Sales Quantity by Type (2024-2034) & (K MT)
Table 84. China Pharma Excipients Revenue by Type (2018-2023) & (US$ Million)
Table 85. China Pharma Excipients Revenue by Type (2024-2034) & (US$ Million)
Table 86. China Pharma Excipients Sales Quantity by Application (2018-2023) & (K MT)
Table 87. China Pharma Excipients Sales Quantity by Application (2024-2034) & (K MT)
Table 88. China Pharma Excipients Revenue by Application (2018-2023) & (US$ Million)
Table 89. China Pharma Excipients Revenue by Application (2024-2034) & (US$ Million)
Table 90. APAC Pharma Excipients Sales Quantity by Company (2018-2023) & (K MT)
Table 91. APAC Pharma Excipients Revenue by Company (2018-2023) & (US$ Million)
Table 92. APAC Pharma Excipients Sales Quantity by Type (2018-2023) & (K MT)
Table 93. APAC Pharma Excipients Sales Quantity by Type (2024-2034) & (K MT)
Table 94. APAC Pharma Excipients Revenue by Type (2018-2023) & (US$ Million)
Table 95. APAC Pharma Excipients Revenue by Type (2024-2034) & (US$ Million)
Table 96. APAC Pharma Excipients Sales Quantity by Application (2018-2023) & (K MT)
Table 97. APAC Pharma Excipients Sales Quantity by Application (2024-2034) & (K MT)
Table 98. APAC Pharma Excipients Revenue by Application (2018-2023) & (US$ Million)
Table 99. APAC Pharma Excipients Revenue by Application (2024-2034) & (US$ Million)
Table 100. APAC Pharma Excipients Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 101. APAC Pharma Excipients Revenue by Region (2018-2023) & (US$ Million)
Table 102. APAC Pharma Excipients Revenue by Region (2024-2034) & (US$ Million)
Table 103. APAC Pharma Excipients Sales Quantity by Region (2018-2023) & (K MT)
Table 104. APAC Pharma Excipients Sales Quantity by Region (2024-2034) & (K MT)
Table 105. Middle East, Africa and Latin America Pharma Excipients Sales Quantity by Company (2018-2023) & (K MT)
Table 106. Middle East, Africa and Latin America Pharma Excipients Revenue by Company (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Pharma Excipients Sales Quantity by Type (2018-2023) & (K MT)
Table 108. Middle East, Africa and Latin America Pharma Excipients Sales Quantity by Type (2024-2034) & (K MT)
Table 109. Middle East, Africa and Latin America Pharma Excipients Revenue by Type (2018-2023) & (US$ Million)
Table 110. Middle East, Africa and Latin America Pharma Excipients Revenue by Type (2024-2034) & (US$ Million)
Table 111. Middle East, Africa and Latin America Pharma Excipients Sales Quantity by Application (2018-2023) & (K MT)
Table 112. Middle East, Africa and Latin America Pharma Excipients Sales Quantity by Application (2024-2034) & (K MT)
Table 113. Middle East, Africa and Latin America Pharma Excipients Revenue by Application (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Pharma Excipients Revenue by Application (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Pharma Excipients Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 116. Middle East, Africa and Latin America Pharma Excipients Revenue by Country (2018-2023) & (US$ Million)
Table 117. Middle East, Africa and Latin America Pharma Excipients Revenue by Country (2024-2034) & (US$ Million)
Table 118. Middle East, Africa and Latin America Pharma Excipients Sales Quantity by Country (2018-2023) & (K MT)
Table 119. Middle East, Africa and Latin America Pharma Excipients Sales Quantity by Country (2024-2034) & (K MT)
Table 120. Archer Daniels Midland (ADM) Company Information
Table 121. Archer Daniels Midland (ADM) Description and Overview
Table 122. Archer Daniels Midland (ADM) Pharma Excipients Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 123. Archer Daniels Midland (ADM) Pharma Excipients Product and Services
Table 124. Archer Daniels Midland (ADM) Pharma Excipients SWOT Analysis
Table 125. Archer Daniels Midland (ADM) Recent Developments
Table 126. BASF Company Information
Table 127. BASF Description and Overview
Table 128. BASF Pharma Excipients Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 129. BASF Pharma Excipients Product and Services
Table 130. BASF Pharma Excipients SWOT Analysis
Table 131. BASF Recent Developments
Table 132. DOW Chemical Company Company Information
Table 133. DOW Chemical Company Description and Overview
Table 134. DOW Chemical Company Pharma Excipients Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 135. DOW Chemical Company Pharma Excipients Product and Services
Table 136. DOW Chemical Company Pharma Excipients SWOT Analysis
Table 137. DOW Chemical Company Recent Developments
Table 138. Evonik Company Information
Table 139. Evonik Description and Overview
Table 140. Evonik Pharma Excipients Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 141. Evonik Pharma Excipients Product and Services
Table 142. Evonik Pharma Excipients SWOT Analysis
Table 143. Evonik Recent Developments
Table 144. J.M. Huber Corporation Company Information
Table 145. J.M. Huber Corporation Description and Overview
Table 146. J.M. Huber Corporation Pharma Excipients Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 147. J.M. Huber Corporation Pharma Excipients Product and Services
Table 148. J.M. Huber Corporation Pharma Excipients SWOT Analysis
Table 149. J.M. Huber Corporation Recent Developments
Table 150. ABITEC Corporation Company Information
Table 151. ABITEC Corporation Description and Overview
Table 152. ABITEC Corporation Pharma Excipients Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 153. ABITEC Corporation Pharma Excipients Product and Services
Table 154. ABITEC Corporation Pharma Excipients SWOT Analysis
Table 155. ABITEC Corporation Recent Developments
Table 156. Cargill Company Information
Table 157. Cargill Description and Overview
Table 158. Cargill Pharma Excipients Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 159. Cargill Pharma Excipients Product and Services
Table 160. Cargill Pharma Excipients SWOT Analysis
Table 161. Cargill Recent Developments
Table 162. Eastman Chemical Company Company Information
Table 163. Eastman Chemical Company Description and Overview
Table 164. Eastman Chemical Company Pharma Excipients Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 165. Eastman Chemical Company Pharma Excipients Product and Services
Table 166. Eastman Chemical Company Pharma Excipients SWOT Analysis
Table 167. Eastman Chemical Company Recent Developments
Table 168. AkzoNobel Company Information
Table 169. AkzoNobel Description and Overview
Table 170. AkzoNobel Pharma Excipients Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 171. AkzoNobel Pharma Excipients Product and Services
Table 172. AkzoNobel Pharma Excipients SWOT Analysis
Table 173. AkzoNobel Recent Developments
Table 174. Key Raw Materials Lists
Table 175. Raw Materials Key Suppliers Lists
Table 176. Pharma Excipients Distributors List
Table 177. Pharma Excipients Customers List
Table 178. Pharma Excipients Market Trends
Table 179. Pharma Excipients Market Drivers
Table 180. Pharma Excipients Market Challenges
Table 181. Pharma Excipients Market Restraints
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharma Excipients Product Picture
Figure 2. Global Pharma Excipients Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Pharma Excipients Market Share by Type in 2024 & 2034
Figure 4. Polymers Product Picture
Figure 5. Alcohols Product Picture
Figure 6. Minerals Product Picture
Figure 7. Sugar Product Picture
Figure 8. Others Product Picture
Figure 9. Global Pharma Excipients Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 10. Global Pharma Excipients Market Share by Application in 2024 & 2034
Figure 11. Oral Solid Dosage Forms (OSDF)
Figure 12. Others
Figure 13. Pharma Excipients Report Years Considered
Figure 14. Global Pharma Excipients Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 15. Global Pharma Excipients Revenue 2018-2034 (US$ Million)
Figure 16. Global Pharma Excipients Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 17. Global Pharma Excipients Sales Quantity 2018-2034 (K MT)
Figure 18. Global Pharma Excipients Sales Quantity Market Share by Region (2018-2023)
Figure 19. Global Pharma Excipients Sales Quantity Market Share by Region (2024-2034)
Figure 20. North America Pharma Excipients Sales Quantity YoY (2018-2034) & (K MT)
Figure 21. North America Pharma Excipients Revenue YoY (2018-2034) & (US$ Million)
Figure 22. Europe Pharma Excipients Sales Quantity YoY (2018-2034) & (K MT)
Figure 23. Europe Pharma Excipients Revenue YoY (2018-2034) & (US$ Million)
Figure 24. China Pharma Excipients Sales Quantity YoY (2018-2034) & (K MT)
Figure 25. China Pharma Excipients Revenue YoY (2018-2034) & (US$ Million)
Figure 26. APAC Pharma Excipients Sales Quantity YoY (2018-2034) & (K MT)
Figure 27. APAC Pharma Excipients Revenue YoY (2018-2034) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Pharma Excipients Sales Quantity YoY (2018-2034) & (K MT)
Figure 29. Middle East, Africa and Latin America Pharma Excipients Revenue YoY (2018-2034) & (US$ Million)
Figure 30. The Top 10 and Top 5 Players Market Share by Pharma Excipients Sales Quantity in 2024
Figure 31. The Top 10 and Top 5 Players Market Share by Pharma Excipients Revenue in 2024
Figure 32. Pharma Excipients Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 33. Global Pharma Excipients Sales Quantity Market Share by Type (2018-2034)
Figure 34. Global Pharma Excipients Revenue Market Share by Type (2018-2034)
Figure 35. Global Pharma Excipients Sales Quantity Market Share by Application (2018-2034)
Figure 36. Global Pharma Excipients Revenue Market Share by Application (2018-2034)
Figure 37. North America Pharma Excipients Revenue Market Share by Company in 2024
Figure 38. North America Pharma Excipients Sales Quantity Market Share by Company in 2024
Figure 39. North America Pharma Excipients Sales Quantity Market Share by Type (2018-2034)
Figure 40. North America Pharma Excipients Revenue Market Share by Type (2018-2034)
Figure 41. North America Pharma Excipients Sales Quantity Market Share by Application (2018-2034)
Figure 42. North America Pharma Excipients Revenue Market Share by Application (2018-2034)
Figure 43. North America Pharma Excipients Revenue Share by Country (2018-2034)
Figure 44. North America Pharma Excipients Sales Quantity Share by Country (2018-2034)
Figure 45. U.S. Pharma Excipients Revenue (2018-2034) & (US$ Million)
Figure 46. Canada Pharma Excipients Revenue (2018-2034) & (US$ Million)
Figure 47. Europe Pharma Excipients Sales Quantity Market Share by Company in 2024
Figure 48. Europe Pharma Excipients Revenue Market Share by Company in 2024
Figure 49. Europe Pharma Excipients Sales Quantity Market Share by Type (2018-2034)
Figure 50. Europe Pharma Excipients Revenue Market Share by Type (2018-2034)
Figure 51. Europe Pharma Excipients Sales Quantity Market Share by Application (2018-2034)
Figure 52. Europe Pharma Excipients Revenue Market Share by Application (2018-2034)
Figure 53. Europe Pharma Excipients Revenue Share by Country (2018-2034)
Figure 54. Europe Pharma Excipients Sales Quantity Share by Country (2018-2034)
Figure 55. Germany Pharma Excipients Revenue (2018-2034) & (US$ Million)
Figure 56. France Pharma Excipients Revenue (2018-2034) & (US$ Million)
Figure 57. U.K. Pharma Excipients Revenue (2018-2034) & (US$ Million)
Figure 58. Italy Pharma Excipients Revenue (2018-2034) & (US$ Million)
Figure 59. Russia Pharma Excipients Revenue (2018-2034) & (US$ Million)
Figure 60. China Pharma Excipients Sales Quantity Market Share by Company in 2024
Figure 61. China Pharma Excipients Revenue Market Share by Company in 2024
Figure 62. China Pharma Excipients Sales Quantity Market Share by Type (2018-2034)
Figure 63. China Pharma Excipients Revenue Market Share by Type (2018-2034)
Figure 64. China Pharma Excipients Sales Quantity Market Share by Application (2018-2034)
Figure 65. China Pharma Excipients Revenue Market Share by Application (2018-2034)
Figure 66. APAC Pharma Excipients Sales Quantity Market Share by Company in 2024
Figure 67. APAC Pharma Excipients Revenue Market Share by Company in 2024
Figure 68. APAC Pharma Excipients Sales Quantity Market Share by Type (2018-2034)
Figure 69. APAC Pharma Excipients Revenue Market Share by Type (2018-2034)
Figure 70. APAC Pharma Excipients Sales Quantity Market Share by Application (2018-2034)
Figure 71. APAC Pharma Excipients Revenue Market Share by Application (2018-2034)
Figure 72. APAC Pharma Excipients Revenue Share by Region (2018-2034)
Figure 73. APAC Pharma Excipients Sales Quantity Share by Region (2018-2034)
Figure 74. Japan Pharma Excipients Revenue (2018-2034) & (US$ Million)
Figure 75. South Korea Pharma Excipients Revenue (2018-2034) & (US$ Million)
Figure 76. China Taiwan Pharma Excipients Revenue (2018-2034) & (US$ Million)
Figure 77. Southeast Asia Pharma Excipients Revenue (2018-2034) & (US$ Million)
Figure 78. India Pharma Excipients Revenue (2018-2034) & (US$ Million)
Figure 79. Middle East, Africa and Latin America Pharma Excipients Sales Quantity Market Share by Company in 2024
Figure 80. Middle East, Africa and Latin America Pharma Excipients Revenue Market Share by Company in 2024
Figure 81. Middle East, Africa and Latin America Pharma Excipients Sales Quantity Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Pharma Excipients Revenue Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Pharma Excipients Sales Quantity Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Pharma Excipients Revenue Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Pharma Excipients Sales Quantity Share by Country (2018-2034)
Figure 86. Middle East, Africa and Latin America Pharma Excipients Revenue Share by Country (2018-2034)
Figure 87. Brazil Pharma Excipients Revenue (2018-2034) & (US$ Million)
Figure 88. Mexico Pharma Excipients Revenue (2018-2034) & (US$ Million)
Figure 89. Turkey Pharma Excipients Revenue (2018-2034) & (US$ Million)
Figure 90. Israel Pharma Excipients Revenue (2018-2034) & (US$ Million)
Figure 91. GCC Countries Pharma Excipients Revenue (2018-2034) & (US$ Million)
Figure 92. Pharma Excipients Value Chain
Figure 93. Pharma Excipients Production Process
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed